BUZZ-Hims & Hers Health falls; JP Morgan Chase cuts stake in co

Hims & Hers Health, Inc. Class A -3.53%
JPMorgan Chase & Co. -0.26%

Hims & Hers Health, Inc. Class A

HIMS

19.14

-3.53%

JPMorgan Chase & Co.

JPM

294.60

-0.26%

** Shares of teleheath firm Hims & Hers Health HIMS.N fall 3.8% to $15.83

** Wall Street titan JPMorgan Chase JPM.N has cut its stake in HIMS from 8.1% to 1.7%, a regulatory filing showed as of February 27

** Hims has faced a wave of controversies in recent weeks after announcing and quickly withdrawing a $49 compounded version of Novo Nordisk’s NOVOb.CO weight‑loss drug Wegovy, following legal threats and regulatory scrutiny

** The company when reporting earnings said it would be facing a $65 million burden in the first quarter from changes in the shipping of weight-loss products, which must be personalized for each prescription based on U.S. law

** Including session's move, HIMS stock has halved YTD


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.